SG Americas Securities, LLC - ASTERIAS BIOTHERAPEUTICS INC ownership

ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 64 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ASTERIAS BIOTHERAPEUTICS INC
ValueSharesWeighting
Q4 2017$31,000
-45.6%
13,800
-14.6%
0.00%
-100.0%
Q2 2017$57,000
+50.0%
16,150
+43.7%
0.00%
Q1 2017$38,000
-28.3%
11,235
-49.2%
0.00%
Q2 2016$53,000
+26.2%
22,117
+106.0%
0.00%
Q3 2015$42,00010,7350.00%
Other shareholders
ASTERIAS BIOTHERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 3,699,848$17,019,0002.88%
Northeast Financial Consultants Inc 732,265$3,368,0001.50%
Family Management Corp 12,008$55,0000.04%
Acrospire Investment Management LLC 6,101$28,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 148,054$681,0000.01%
THRIVENT FINANCIAL FOR LUTHERANS 413,278$1,901,0000.01%
OXFORD ASSET MANAGEMENT LLP 48,790$224,0000.01%
Parallel Advisors, LLC 3,538$16,0000.00%
Squarepoint Ops LLC 15,690$72,0000.00%
WILLIAMS JONES & ASSOCIATES LLC 15,100$69,0000.00%
View complete list of ASTERIAS BIOTHERAPEUTICS INC shareholders